SP

Sushil Prataprao Borde

Active Director Director DIN 01713369
DIN 01713369 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushil Prataprao Borde

Data last updated:

Sushil Prataprao Borde is a Director at Affex Healthcare Private Limited (since 2025) and Director at Anjani Mashelkar Foundation (since 2025).

DIN 01713369
Primary Designation Director
First Appointment 13 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Affex Healthcare Private Limited U86900PN2025PTC247095
Director01 Oct 20252025Active
Anjani Mashelkar Foundation U88900PN2025NPL237042
Director13 Jan 20252025Active

Board colleagues of Sushil Prataprao Borde

Directorship timeline

Open interactive timeline →
Affex Healthcare Private Limited
Anjani Mashelkar Foundation
Premium access

Shareholding and investment profile for Sushil Prataprao Borde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushil Prataprao Borde

Sushil Prataprao Borde currently holds 2 directorships: Affex Healthcare Private Limited (Director, since 01 Oct 2025); Anjani Mashelkar Foundation (Director, since 13 Jan 2025).

Sushil Prataprao Borde was first appointed on 13 Jan 2025 as Director at Anjani Mashelkar Foundation.

The current boards of Sushil Prataprao Borde's companies include Raghunath Anant Mashelkar (Affex Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available